Tichakunda Mharazanye: A New Year, New Challenges, And New Milestones
Tichakunda Mharazanye, Pharmacy student at RIMT University, shared on LinkedIn about a recent article he and his colleague co-authored, adding:
”A new year, new challenges, and new milestones
The start of this year came with its fair share of pressure, tight deadlines and moments of selfdoubt.
Staying consistent, focused and curious helped me push through and l am grateful to begin the year by sharing my latest review publication.
Our work explores hemophilia beyond clotting factors, focusing on albumin as an underappreciated prognostic and diagnostic marker.
The review highlights how albumin reflects disease burden, influences bleeding severity and joint outcomes, and plays a key role in the pharmacokinetics of modern hemophilia therapies opening doors for more personalized prophylaxis.
Grateful for the learning process, the resilience it builds, and the opportunity to contribute to advancing patient-centered care in hemophilia.”
Title: Hemophilia And Albumin: Quantitative Analysis For Prognostic And Diagnostic Applications
Authors: Tichakunda Xavier Mharazanye, Shaun Muponda
Read the Full Article on The International Journal of Engineering Development and Research

More winner stories featured in Hemostasis Today.
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?
-
Sep 30, 2026, 13:03Amira Mohy: Diagnostic Flow Cytometry Panels for Hematological Malignancies
-
Sep 30, 2026, 12:52Paul Watton: Could Repetitive Head Impacts Leave a Molecular Memory?
-
Sep 30, 2026, 12:41The Journey to ISTH 2027 Starts in Vancouver
-
Sep 30, 2026, 11:36Basit Ali: A Closer Look at CT Venography
-
Sep 30, 2026, 11:16Christina Pohlman: Could aPL Levels Help Predict Stroke Recurrence?
-
Sep 30, 2026, 10:55Rana Al Hrout: Diagnostic Approach to Hypochromic Microcytic Anemia
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke